A Phase I/II study of lapatinib plus non-peglated liposomal doxorubicin in patients with HER2+ve metastatic breast cancer following disease progression during, or after, treatment with trastuzumab and taxanes

Hdl Handle:
http://hdl.handle.net/10147/138742
Title:
A Phase I/II study of lapatinib plus non-peglated liposomal doxorubicin in patients with HER2+ve metastatic breast cancer following disease progression during, or after, treatment with trastuzumab and taxanes
Issue Date:
3-Aug-2011
URI:
http://hdl.handle.net/10147/138742
Ethical Approval:
N/A
Start Date:
2010
Principal Investigator:
Keane, Maccon Dr.

Full metadata record

DC FieldValue Language
dc.date.accessioned2011-08-03T15:05:30Z-
dc.date.available2011-08-03T15:05:30Z-
dc.date.issued2011-08-03T15:05:30Z-
dc.identifier.urihttp://hdl.handle.net/10147/138742-
dc.titleA Phase I/II study of lapatinib plus non-peglated liposomal doxorubicin in patients with HER2+ve metastatic breast cancer following disease progression during, or after, treatment with trastuzumab and taxanesen
dc.type.qualificationlevelDoctoralen
cr.approval.ethicalN/Aen
cr.contributor.principalKeane, Maccon Dr.en
cr.date.start2010-
dc.description.provinceConnacht-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.